RxAlly names general counsel, EVP corporate development
LEESBURG, Va. — A coalition of more than 22,000 pharmacies around the country has expanded its leadership team.
RxAlly announced that Tom O’Grady will serve as general counsel and EVP corporate development for the alliance. RxAlly said O’Grady brings more than 30 years of corporate and transactional law experience to his role as general counsel, and in his corporate development role, O’Grady will be structuring business relationships between RxAlly and the companies and businesses that RxAlly will be working with as it continues to align pharmacies and pharmacists, the patients they serve, and the payer community.
O’Grady joins RxAlly from McGuireWoods LLP, where he focused on transactional law for health care and other technology-enabled companies.
"RxAlly is adding an invaluable asset in Tom O’Grady," RxAlly CEO Bruce Roberts saod. "His work in helping to establish RxAlly as our external General Counsel was invaluable. His experience in structuring transactions to achieve aligned business goals is going to be important to us at RxAlly as we focus on how America’s pharmacies will deliver better health to patients, aligning the interests of patients, payers and providers."
Aisle411 store map app now directing consumer traffic in all Walgreens stores
PALO ALTO, Calif. — Aisle411, a mobile retail navigation service, on Tuesday announced that its virtual mapping and navigation smartphone application is available to use in all of Walgreens’ 7,907 drug stores nationwide.
With Aisle411’s in-store mapping platform, customers can use their smartphones to view maps of any Walgreens store, allowing shoppers to locate products down to a particular section of each aisle. Walgreens is the first national retailer with all of its stores mapped in a mobile application, Aisle411 stated.
"Retailers are constantly looking for solutions to enhance their customer’s store visits and improve convenience," stated Nathan Pettyjohn, CEO of Aisle411. "Aisle411 allows retailers to empower their shoppers by providing information, such as product locations, right in customers’ hands, making the shopping experience more convenient and fun."
Nearly 84% of shoppers have difficulty finding products on store shelves, and more than 20% of shoppers leave the store without their full purchase intent, Aisle411 discovered in a recent consumer survey. The Aisle411 app is available for free from the iPhone App Store and the Google Play store.
J&J seeks approval for Simponi in ulcerative colitis
HORSHAM, Pa. — A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs.
Janssen Biotech and Janssen Biologics B.V. announced the submission of a supplemental regulatory application to the Food and Drug Administration for Simponi (golimumab) for treatment of moderately to severely active ulcerative colitis, an inflammatory bowel disease that affects about 700,000 people in the United States. The drug already is approved for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
"We are pleased to bring forward submissions for Simponi as a potential therapeutic option for patients who fail to respond to conventional treatments and who face the continued debilitating effects of living with ulcerative colitis and, in some circumstances, a decision for surgery," Janssen Research and Development VP and head of immunology development Jerome Boscia said.